Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2003

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Sarcoma
Interventions
DRUG

soblidotin

Trial Locations (6)

10021

Memorial Sloan-Kettering Cancer Center, New York

10032

Herbert Irving Comprehensive Cancer Center at Columbia University, New York

35294-3300

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham

46202-5289

Indiana University Cancer Center, Indianapolis

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

00927-5800

Veterans Affairs Medical Center - San Juan, San Juan

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Daiichi Sankyo

INDUSTRY